This metabolite provides a PDE selectivity profile comparable to sildenafil and an in vitro potency for PDE5 close to fifty% with the guardian drug. Plasma concentrations of this metabolite are somewhere around forty% of All those witnessed for sildenafil, so that the metabolite accounts for around 20% of sildenafil's pharmacologic results.The AUC